Virtual Screening for Potential Substances for the Prophylaxis of HIV Infection in Libraries of Commercially Available Organic Compounds

Author： Lagunin A.   Filimonov D.   Gloriozova T.   Tarasova O.   Zakharov A.   Guasch L.   Nicklaus M.   Poroikov V.  

Publisher： Springer Publishing Company

ISSN： 0091-150X

Source： Pharmaceutical Chemistry Journal, Vol.47, Iss.7, 2013-10, pp. : 343-360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug-Likeness and Increased Hydrophobicity of Commercially Available Compound Libraries for Drug Screening

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 14, 2012-07 ,pp. : 1500-1513

Bentham Science Publishers

Access to resources Recommend Favorite

Interruption of secondary prophylaxis in HIV infection

By  

Inpharma, Vol. 1, Iss. 1360, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Commercially Available, FDA-approved Epigenetic Modifiers As Therapeutic Agents in Bacterial Infection

By  

Clinical Anti-Inflammatory & Anti-Allergy Drugs, Vol. 2, Iss. 1, 2015-04 ,pp. : 79-88

Bentham Science Publishers

Access to resources Recommend Favorite

Nevirapine not recommended for prophylaxis of HIV-1 infection

By  

Inpharma, Vol. 1, Iss. 1301, 2001-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Virtual screening of chemical libraries for drug discovery

By Green Darren VS  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 9, 2008-09 ,pp. : 1011-1026

Informa Healthcare

Access to resources Recommend Favorite